OMEROS CORP Net Income
OMEROS CORP (OMER) reported Net Income of $13.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-12
- OMEROS CORP net income (loss) attributable to parent for the quarter ending 2026-06-30 was $13.23M.
- OMEROS CORP net income (loss) attributable to parent for the quarter ending 2026-03-31 was $56.06M.
- OMEROS CORP net income (loss) attributable to parent for the quarter ending 2025-12-31 was $86.45M.
- OMEROS CORP net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$30.92M.
- OMEROS CORP net income (loss) attributable to parent for fiscal 2025 was -$3.35M.
- OMEROS CORP net income (loss) attributable to parent for fiscal 2024 was -$156.81M.
- OMEROS CORP net income (loss) attributable to parent for fiscal 2023 was -$117.81M, a 348.46% decline from fiscal 2022.
- OMEROS CORP net income (loss) attributable to parent for fiscal 2022 was $47.42M, a 75.59% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 204 month | Net Income (Loss) Attributable to Parent 207 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.23M 10-Q · filed 2026-08-12 | $69.29M 10-Q · filed 2026-08-12 | $155.74M derived: sum of 3 quarters · filed 2026-08-12 | $124.83M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $56.06M 10-Q · filed 2026-08-12 | $142.51M derived: sum of 2 quarters · filed 2026-08-12 | $111.59M derived: sum of 3 quarters · filed 2026-08-12 | $86.17M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $86.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $55.53M derived: sum of 2 quarters · filed 2026-03-31 | $30.11M derived: sum of 3 quarters · filed 2026-08-12 | -$3.35M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$30.92M 10-Q · filed 2025-11-13 | -$56.34M derived: sum of 2 quarters · filed 2026-08-12 | -$89.80M 10-Q · filed 2025-11-13 | -$121.16M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$25.42M 10-Q · filed 2026-08-12 | -$58.88M 10-Q · filed 2026-08-12 | -$90.24M derived: sum of 3 quarters · filed 2026-08-12 | -$122.47M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$33.46M 10-Q · filed 2026-08-12 | -$64.82M derived: sum of 2 quarters · filed 2026-08-12 | -$97.05M derived: sum of 3 quarters · filed 2026-08-12 | -$153.09M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2024-12-31 | -$31.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$63.59M derived: sum of 2 quarters · filed 2026-03-31 | -$119.63M derived: sum of 3 quarters · filed 2026-03-31 | -$156.81M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$32.23M 10-Q · filed 2025-11-13 | -$88.27M derived: sum of 2 quarters · filed 2025-11-13 | -$125.46M 10-Q · filed 2025-11-13 | -$134.53M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-06-30 | -$56.04M 10-Q · filed 2025-11-13 | -$93.22M 10-Q · filed 2025-08-14 | -$102.29M derived: sum of 3 quarters · filed 2026-03-31 | -$140.04M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-03-31 | -$37.18M 10-Q · filed 2025-11-13 | -$46.25M derived: sum of 2 quarters · filed 2026-03-31 | -$84.00M derived: sum of 3 quarters · filed 2026-03-31 | -$121.30M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2023-12-31 | -$9.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$46.82M derived: sum of 2 quarters · filed 2026-03-31 | -$84.11M derived: sum of 3 quarters · filed 2026-03-31 | -$117.81M 10-K · filed 2026-03-31 | ||
| 2023-09-30 | -$37.75M 10-Q · filed 2024-11-13 | -$75.04M derived: sum of 2 quarters · filed 2024-11-13 | -$108.75M 10-Q · filed 2024-11-13 | $19.99M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-06-30 | -$37.29M 10-Q · filed 2024-11-13 | -$71.00M 10-Q · filed 2024-08-07 | $57.74M derived: sum of 3 quarters · filed 2025-03-31 | $40.28M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-03-31 | -$33.70M 10-Q · filed 2024-11-13 | $95.03M derived: sum of 2 quarters · filed 2025-03-31 | $77.58M derived: sum of 3 quarters · filed 2025-03-31 | $46.73M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2022-12-31 | $128.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $111.28M derived: sum of 2 quarters · filed 2025-03-31 | $80.43M derived: sum of 3 quarters · filed 2025-03-31 | $47.42M 10-K · filed 2025-03-31 | ||
| 2022-09-30 | -$17.46M 10-Q · filed 2023-11-09 | -$48.30M derived: sum of 2 quarters · filed 2023-11-09 | -$81.32M 10-Q · filed 2023-11-09 | $199.31M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-06-30 | -$30.85M 10-Q · filed 2023-11-09 | -$63.86M 10-Q · filed 2023-08-09 | $216.76M derived: sum of 3 quarters · filed 2024-04-01 | $194.06M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-03-31 | -$33.01M 10-Q · filed 2023-11-09 | $247.61M derived: sum of 2 quarters · filed 2024-04-01 | $224.91M derived: sum of 3 quarters · filed 2024-04-01 | $196.31M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2021-12-31 | $280.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $257.92M derived: sum of 2 quarters · filed 2024-04-01 | $229.32M derived: sum of 3 quarters · filed 2024-04-01 | $194.24M 10-K · filed 2024-04-01 | ||
| 2021-09-30 | -$22.70M 10-Q · filed 2022-11-09 | -$51.30M derived: sum of 2 quarters · filed 2022-11-09 | -$86.39M 10-Q · filed 2022-11-09 | -$123.66M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$28.59M 10-Q · filed 2022-11-09 | -$63.68M 10-Q · filed 2022-08-09 | -$100.96M derived: sum of 3 quarters · filed 2022-11-09 | -$139.42M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-03-31 | -$35.09M 10-Q · filed 2022-11-09 | -$72.36M derived: sum of 2 quarters · filed 2022-11-09 | -$110.83M derived: sum of 3 quarters · filed 2022-11-09 | -$144.12M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2020-12-31 | -$37.27M 10-K · filed 2021-03-01 | -$75.74M derived: sum of 2 quarters · filed 2021-11-09 | -$109.03M derived: sum of 3 quarters · filed 2021-11-09 | -$138.06M 10-K · filed 2023-03-13 | ||
| 2020-09-30 | -$38.46M 10-Q · filed 2021-11-09 | -$71.76M derived: sum of 2 quarters · filed 2021-11-09 | -$100.79M 10-Q · filed 2021-11-09 | -$130.01M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$33.29M 10-Q · filed 2021-11-09 | -$62.33M 10-Q · filed 2021-08-09 | -$91.55M derived: sum of 3 quarters · filed 2021-11-09 | -$108.01M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-03-31 | -$29.03M 10-Q · filed 2021-11-09 | -$58.26M derived: sum of 2 quarters · filed 2021-11-09 | -$74.72M derived: sum of 3 quarters · filed 2021-11-09 | -$89.17M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2019-12-31 | -$29.23M 10-K · filed 2021-03-01 | -$45.69M derived: sum of 2 quarters · filed 2021-03-01 | -$60.14M derived: sum of 3 quarters · filed 2021-03-01 | -$84.49M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$16.46M 10-K · filed 2021-03-01 | -$30.92M derived: sum of 2 quarters · filed 2021-03-01 | -$55.26M 10-Q · filed 2020-11-09 | -$78.80M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | -$14.45M 10-K · filed 2021-03-01 | -$38.80M 10-Q · filed 2020-08-10 | -$62.33M derived: sum of 3 quarters · filed 2021-03-01 | -$101.80M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$24.34M 10-K · filed 2021-03-01 | -$47.88M derived: sum of 2 quarters · filed 2021-03-01 | -$87.35M derived: sum of 3 quarters · filed 2021-03-01 | -$121.05M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$23.53M 10-K · filed 2020-03-02 | -$63.01M derived: sum of 2 quarters · filed 2020-03-02 | -$96.70M derived: sum of 3 quarters · filed 2020-03-02 | -$126.76M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$39.47M 10-K · filed 2020-03-02 | -$73.17M derived: sum of 2 quarters · filed 2020-03-02 | -$103.22M 10-Q · filed 2019-11-12 | -$119.77M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$33.70M 10-K · filed 2020-03-02 | -$63.75M 10-Q · filed 2019-08-08 | -$80.30M derived: sum of 3 quarters · filed 2020-03-02 | -$87.78M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$30.05M 10-K · filed 2020-03-02 | -$46.60M derived: sum of 2 quarters · filed 2020-03-02 | -$54.09M derived: sum of 3 quarters · filed 2020-03-02 | -$68.45M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$16.55M 10-K · filed 2019-03-01 | -$24.03M derived: sum of 2 quarters · filed 2019-03-01 | -$38.39M derived: sum of 3 quarters · filed 2019-03-01 | -$53.48M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$7.48M 10-K · filed 2019-03-01 | -$21.84M derived: sum of 2 quarters · filed 2019-03-01 | -$36.93M 10-Q · filed 2018-11-08 | -$56.56M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$14.36M 10-K · filed 2019-03-01 | -$29.45M 10-Q · filed 2018-08-09 | -$49.08M derived: sum of 3 quarters · filed 2019-03-01 | -$63.04M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$15.09M 10-K · filed 2019-03-01 | -$34.72M derived: sum of 2 quarters · filed 2019-03-01 | -$48.68M derived: sum of 3 quarters · filed 2019-03-01 | -$61.30M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | -$19.63M 10-K · filed 2018-03-01 | -$33.59M derived: sum of 2 quarters · filed 2018-03-01 | -$46.21M derived: sum of 3 quarters · filed 2018-03-01 | -$66.75M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$13.96M 10-K · filed 2018-03-01 | -$26.57M derived: sum of 2 quarters · filed 2018-03-01 | -$47.11M 10-Q · filed 2017-11-09 | -$66.94M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | -$12.61M 10-K · filed 2018-03-01 | -$33.15M 10-Q · filed 2017-08-08 | -$52.98M derived: sum of 3 quarters · filed 2018-03-01 | -$72.90M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | -$20.54M 10-K · filed 2018-03-01 | -$40.37M derived: sum of 2 quarters · filed 2018-03-01 | -$60.29M derived: sum of 3 quarters · filed 2018-03-01 | -$76.97M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | -$19.83M 10-K · filed 2017-03-16 | -$39.75M derived: sum of 2 quarters · filed 2017-03-16 | -$56.43M derived: sum of 3 quarters · filed 2017-03-16 | -$75.10M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | -$19.92M 10-K · filed 2017-03-16 | -$36.60M derived: sum of 2 quarters · filed 2017-03-16 | -$55.27M 10-Q · filed 2016-11-09 | -$75.98M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | -$16.68M 10-K · filed 2017-03-16 | -$35.35M 10-Q · filed 2016-08-09 | -$56.06M derived: sum of 3 quarters · filed 2017-03-16 | -$74.39M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | -$18.67M 10-K · filed 2017-03-16 | -$39.38M derived: sum of 2 quarters · filed 2017-03-16 | -$57.71M derived: sum of 3 quarters · filed 2017-03-16 | -$75.70M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | -$20.71M 10-K · filed 2016-03-15 | -$39.04M derived: sum of 2 quarters · filed 2016-03-15 | -$57.03M derived: sum of 3 quarters · filed 2016-03-15 | -$73.67M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | -$18.33M 10-K · filed 2016-03-15 | -$36.32M derived: sum of 2 quarters · filed 2016-03-15 | -$52.96M 10-Q · filed 2015-11-09 | -$54.80M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | -$17.99M 10-K · filed 2016-03-15 | -$34.63M 10-Q · filed 2015-08-10 | -$36.48M derived: sum of 3 quarters · filed 2016-03-15 | -$50.35M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | -$16.64M 10-K · filed 2016-03-15 | -$18.49M derived: sum of 2 quarters · filed 2016-03-15 | -$32.36M derived: sum of 3 quarters · filed 2016-03-15 | -$45.95M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | -$1.84M 10-K · filed 2015-03-16 | -$15.71M derived: sum of 2 quarters · filed 2015-03-16 | -$29.31M derived: sum of 3 quarters · filed 2015-03-16 | -$39.80M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | -$13.87M 10-K · filed 2015-03-16 | -$27.46M derived: sum of 2 quarters · filed 2015-03-16 | -$37.95M 10-Q · filed 2014-11-10 | -$45.69M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | -$13.59M 10-K · filed 2015-03-16 | -$24.08M 10-Q · filed 2014-08-11 | -$31.82M derived: sum of 3 quarters · filed 2015-03-16 | -$45.09M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | -$10.49M 10-K · filed 2015-03-16 | -$18.22M derived: sum of 2 quarters · filed 2015-03-16 | -$31.50M derived: sum of 3 quarters · filed 2015-03-16 | -$40.04M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | -$7.73M 10-K · filed 2014-03-13 | -$21.01M derived: sum of 2 quarters · filed 2014-03-13 | -$29.55M derived: sum of 3 quarters · filed 2014-03-13 | -$38.44M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | -$13.28M 10-K · filed 2014-03-13 | -$21.82M derived: sum of 2 quarters · filed 2014-03-13 | -$30.71M 10-Q · filed 2013-11-07 | -$40.91M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | -$8.54M 10-K · filed 2014-03-13 | -$17.43M 10-Q · filed 2013-08-09 | -$27.64M derived: sum of 3 quarters · filed 2014-03-13 | -$34.15M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | -$8.89M 10-K · filed 2014-03-13 | -$19.10M derived: sum of 2 quarters · filed 2014-03-13 | -$25.61M derived: sum of 3 quarters · filed 2014-03-13 | -$30.90M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | -$10.20M 10-K · filed 2013-03-18 | -$16.71M derived: sum of 2 quarters · filed 2013-03-18 | -$22.00M derived: sum of 3 quarters · filed 2013-03-18 | -$28.55M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | -$6.51M 10-K · filed 2013-03-18 | -$11.80M derived: sum of 2 quarters · filed 2013-03-18 | -$18.34M 10-Q · filed 2012-11-09 | -$25.58M derived: sum of 4 quarters · filed 2013-03-18 | -$165.93M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | -$5.29M 10-K · filed 2013-03-18 | -$11.83M 10-Q · filed 2012-08-07 | -$19.06M derived: sum of 3 quarters · filed 2013-03-18 | -$26.62M derived: sum of 4 quarters · filed 2013-03-18 | -$159.42M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | -$6.54M 10-K · filed 2013-03-18 | -$13.77M derived: sum of 2 quarters · filed 2013-03-18 | -$21.33M derived: sum of 3 quarters · filed 2013-03-18 | -$29.13M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2010-12-31 | -$7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$14.79M derived: sum of 2 quarters · filed 2013-03-18 | -$22.59M derived: sum of 3 quarters · filed 2013-03-18 | -$29.25M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | -$7.55M 10-Q · filed 2011-11-08 | -$15.36M derived: sum of 2 quarters · filed 2011-11-08 | -$22.02M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | -$7.80M 10-Q · filed 2011-08-09 | -$14.46M 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | -$21.09M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |